Medtronic grows revenue, beats profit mark
Middle East North Africa - Financial Network

Demand More is a registered trade mark of MENAFN.COM

 
GFT_ldr_Feb4
 
  Quotes: US MENA   Enter Symbol: NewsLetter: Search News: advanced
 Home  |  MENAFN News  |  Global News RELATED: Global News Regional News News Search

Medtronic grows revenue, beats profit mark  Join our daily free Newsletter

MarketWatch.com-Tuesday, November 24, 2009
Digg This Article: Medtronic grows revenue, beats profit mark Share This Article: Medtronic grows revenue, beats profit mark Add to Delicious Seed this article Buzz this article Add to Reddit Add to furl Add to stumbleupon Add to Mixx!

Medtronic grows revenue, beats profit target

Last Update: 8:32 AM ET Nov 24, 2009

NEW YORK (MarketWatch) -- Shares of Medtronic rose Tuesday after the medical technology specialist said its second-quarter profit rose 59% after the benefit of a one-time litigation gain and an accounting change.

Medtronic MDT earned $868 million, or 78 cents a share, up from $547 million, or 48 cents a share, in the year-ago period.

Revenue rose 8%, to $3.8 billion.

On an adjusted basis, net earnings rose 12% to $850 million, or 77 cents a share.

Analysts surveyed by FactSet Research had expected, on average, net earnings of 74 cents a share on revenue of $3.75 billion.

The Minneapolis-based company also raised its profit target for the fiscal year 2010 to a range of $3.17 to $3.22 a share, ahead of the Wall Street target of $3.14 a share.

The company reiterated its 5% to 8% constant currency revenue growth outlook for the foreseeable future, including the second half of fiscal year 2010.

Shares of Medtronic rose 5% to 42.44 in pre-market trades on Tuesday.



International Provider
Feb 09, 2010 ECB flight change boosts Greek rescue speculation, MarketWatch.com
Analysts say news Tuesday that the European Central Bank president will return early from Australia to attend a meeting of European Union leaders in Brussels is providing the euro and financial markets with a lift.
Feb 09, 2010 Drug stocks gain; Cell Therapeutics rebounds, MarketWatch.com
Drug stocks gain in early action while shares of Cell Therapeutics bounced back after diving almost 25% on Monday over concerns about its new non-Hodgkin's lymphoma treatment pixantrone.
Feb 09, 2010 Europe stocks buoyed by rescue hopes for Greece, MarketWatch.com
Stocks in Europe trade mixed-to-slightly higher as worries about Greece's finances appear to abate and as earnings news is eyed.
Feb 09, 2010 Updates, advisories and surprises, MarketWatch.com
A roundup of the latest corporate earnings reports and what companies are saying about future quarters.
Feb 09, 2010 Financial stocks rise as Europe worries moderate, MarketWatch.com
Earnings reports buoy investor spirits dampened over the last several days by worry about turmoil in European economies.
Feb 09, 2010 NYSE Euronext rallies after profit tops forecasts, MarketWatch.com
The stock-exchange operator NYSE Euronext avoids the impairment charges that weighed on its results a year earlier as its profit tops estimates.
Feb 09, 2010 Pulte sees smaller loss after charges, tax gains, MarketWatch.com
The home-building giant that acquired Centex last year narrows its fourth-quarter loss as its bottom line is hit by charges of more than $900 million.
Feb 09, 2010 U.S. futures recover after sub-10,000 Dow close, MarketWatch.com
U.S. stock futures are stronger Tuesday, recovering after the Dow Jones Industrial Average finished below the 10,000 mark for the first time since early November.
Feb 09, 2010 U.S. futures recover after sub-10,000 Dow close, MarketWatch.com
U.S. stock futures are stronger Tuesday, recovering after the Dow Jones Industrial Average finished below the 10,000 mark for the first time since early November.
Feb 09, 2010 UBS swings to profit, but outflows accelerate, MarketWatch.com
Fourth-quarter profit at UBS is helped by lower costs and a tax credit, though the outflow of client money from its wealth-management arm accelerates.
more...

GFCMarkets


GFT_Square_Feb1
Google
Terms of Service  |   Privacy Policy  |   Contact Us |   Advertise  |   About MENAFN  |   Career Opportunities  |   Feedback
Copyright ©2000 All Rights Reserved.